Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms
Introduction
Bacterial resistance has become a major public health problem.1 In recent years, there have been frequent publications regarding resistant bacteria, while there has been no increase in the development of new antibiotics.2, 3 Current antibiotics are worldwide less effective due to the expression of various resistance mechanisms, which are having a major clinical, epidemiological and microbiologically impact.4 Multidrug-resistant organisms (MDRO) are labeled as such because of resistance to more than one antimicrobial agent. Some authors have referred to those bacteria that are potentially resistant and that may acquire a variety of mechanisms of resistance to multiple antibiotics.5, 6 In addition, the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) ECDC/CDC panel created a standardized international terminology with which to describe acquired resistance profiles of MDRO: Single multidrug-resistant (MDRs), extensively drug-resistant (XDR) and pandrug-resistant organisms (PDR).7 Although widespread, this classification lacks validation in clinical practice. In this study, we aimed to determine whether patients with MDRO manifested a worse clinical outcome and whether substantial differences existed when comparing different acquired resistance profiles with those with Intensive-Care-Unit acquired pneumonia (ICUAP).
Section snippets
Study population
The study was conducted in 6 specialized ICUs in an 800-bed university hospital. The investigators conducted daily rounds in the different ICUs. Patients aged over 18 years who had been admitted to these ICUs for at least 48 h with clinical suspicion of ICUAP were prospectively and consecutively included in the study. The ethics committee of the hospital approved the study (IRB Committee name: Hospital Clinic Barcelona/Project approval number IRB 3009/5453) and written informed consent was
Results
343 patients with ICUAP were prospectively enrolled (Fig. 1), 140 patients had no microbiological confirmation (41%), 82 patients (24%) developed ICUAP with non-MDRO pathogens, whereas 121 (35%) with MDRO. Mean age was 63.1 ± 14.5 years, 236 (68.8%) patients were male, and SAPS II score on admission was 39.1 ± 12.8 points for the patients included in the analysis.
Of the 203 patients with definite microbiology confirmation, 82 patients (40.4%) developed ICUAP with non-MDRO, whereas 121 (59.6%)
Discussion
In the current study, we validated a new classification of MDRO, including those with no microbiological confirmation based on the ECDC and CDC classification in a population of ICUAP. This study has two important findings: first, the high prevalence of MDRO observed in our study population carrying a higher mortality than non-resistant pathogens, even when patients with no microbiological confirmation were included in the analysis; and second the increased use of health care resources
Conclusions
In summary, based on our data, only patients with MDRO had a higher ICU-mortality than non-MDRO and no microbiological confirmation and a significantly higher ICU resources use, as defined by fewer MV free days and shorter ICU length of stay than patients with MDRO however no microbiological confirmation patients had more often antibiotic consumption than culture positive ones. Risk factors for MDRO may be important for the selection of initial antimicrobial therapy, in addition to local
Authors' contributions
IM-L & AT assisted in the design of the study coordinated patient recruitment, analyzed and interpreted the data and assisted in writing the paper. MR, ST, FdR, LF & GLB made important contributions to the acquisition and analysis of data. IML, PR, ED & GLB were involved in revising the manuscript critically for important intellectual content. IM-L, MF & AT made substantial contributions to the conception, design, analysis and interpretation of data and revised the final manuscript version. All
Conflict of interest
The authors have no conflict of interest to disclose.
References (24)
- et al.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Clin Microbiol Infect
(2012) - et al.
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing enterobacteriaceae, carbapenem-resistant enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa
Mayo Clin Proc
(2011) - et al.
Impact of clinical guidelines in the management of severe hospital-acquired pneumonia
Chest
(2005) - et al.
Are infections due to resistant pathogens associated with a worse outcome in critically ill patients?
J Infect
(2003) Factors impacting on the problem of antibiotic resistance
J Antimicrob Chemother
(2002)The 10 x ’20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020
Clin Infect Dis
(2010)- Martín-Loeches I, Diaz E, Vallés J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care [Internet]....
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our Worst Nightmare?
Clin Infect Dis
(2002)- et al.
Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America
Clin Infect Dis
(2009) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE
(2008)
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure
N Engl J Med
Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid
Am Rev Respir Dis
Cited by (126)
Risk of multi-drug-resistant organism acquisition from prior bed occupants in the intensive care unit: a meta-analysis
2023, Journal of Hospital InfectionGraphene oxide assisting the visual detection of Salmonella by CRISPR/Cas12a
2023, Microchemical JournalAssociation between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal
2022, Infection Control and Hospital EpidemiologyA dynamic nomogram to predict invasive fungal super-infection during healthcare-associated bacterial infection in intensive care unit patients: an ambispective cohort study in China
2024, Frontiers in Cellular and Infection MicrobiologyMolecular antimicrobial susceptibility testing in sepsis
2024, Future Microbiology